Meda Considering Sale Of US Business
This article was originally published in Scrip
Executive Summary
Meda AB acknowledged rumors about the imminent sale of its US pharmaceutical business on Aug. 28, and while the Swedish company would not comment on the conjecture, it hinted that a transaction of some sort may be imminent.